Koch Foundation

NOVA Science Trust Logo

Draper





  
      <div class="rich-text"><section class="entry-content instapaper_body clearfix" itemprop="articleBody">
 <div class="add-container clearfix" id="add-block-placer">
 </div>
 <p>
  Over a decade ago, the Human Genome Project deciphered the “human instruction book” of our DNA, but how cells develop vastly different functions using the same genetic instructional text has remained largely a mystery.
 </p>
 <p>
  As of yesterday, it became a bit less mysterious. A massive NIH consortium called the Roadmap Epigenomics Program published eight papers in the journal Nature which report on their efforts to map epigenetic modifications, or the changes to DNA that don’t alter its code. These subtle modifications make genes more or less likely to be expressed, and the collection of epigenetic modifications is called the epigenome.
 </p>
 
            <figure class="richtext-image full-width"><img alt="DNA-molecule" class="richtext-image full-width" height="450" width="800"
            src="/wgbh/nova/media/images/dna-molecule.width-800.jpg"/><figcaption>
  A handful of new studies provide epigenetic roadmaps to understanding the human genome in action.
 <div class="credit"></div></figcaption>
            </figure>
            
 <p>
  One of the eight studies
  <a href="http://www.nature.com/nature/journal/v518/n7539/full/nature14248.html#f2">
   mapped over 100 epigenomes
  </a>
  characterizing every epigenetic modification occurring in human tissue cells. “These 111 reference epigenome maps are essentially a vocabulary book that helps us decipher each DNA segment in distinct cell and tissue types,” Roadmap researcher Bing Ren, a professor of cellular and molecular medicine at the University of California, San Diego, said in
  <a href="http://www.nih.gov/news/health/feb2015/niehs-18.htm">
   a news release
  </a>
  . “These maps are like snapshots of the human genome in action.”
 </p>
 <p>
  This kind of mapping has challenged the field because of the huge amount of data needed to make sense of the chaotic arrangements of genes and their regulators. “The genome hasn’t nicely arranged the regulatory elements to be cheek by jowl with the elements they regulate,” Broad Institute director
  <a href="http://www.nytimes.com/2015/02/19/health/scientists-shed-light-on-circuits-that-control-genes.html">
   Eric Lander told Gina Kolata
  </a>
  at The New York Times. “It can be very hard to figure out which regulator lines up with which genes.”
 </p>
 <p>
  Here’s how Lander described the detective process used to Kolata:
 </p>
 <blockquote>
  <p>
   If you knew when service on the Red Line was disrupted and when various employees were late for work, you might be able to infer which employees lived on the Red Line, he said. Likewise, when a genetic circuit was shut down, certain genes would be turned off. That would indicate that those genes were connected, like the employees who were late to work when the Red Line shut down.
  </p>
 </blockquote>
 <p>
  Diseases can be linked to epigenetic variations as well. For example, another of the eight papers published yesterday
  <a href="http://www.nature.com/nature/journal/v518/n7539/full/nature14252.html">
   proposed
  </a>
  that the roots of Alzheimer’s disease lie in immune cell genetic dysfunction and epigenetic alterations in brain cells.
 </p>
 <p>
  Creating an epigenetic road map is a huge step, but it’s just a first step. As Collins wrote in 2001 when the human genome had been mostly mapped, “This is not even the beginning of the end. But it may be the end of the beginning.”
 </p>
</section>
</div>
  

  
      <div class="rich-text"><p>
 Photo Credit:
 <a href="http://commons.wikimedia.org/wiki/File:DNA-molecule2.jpg">
  ynse / Wikimedia Commons
 </a>
</p></div>
  



In Once-Mysterious Epigenome, Scientists Find What Turns Genes On





  
      <div class="rich-text"><section class="entry-content instapaper_body clearfix" itemprop="articleBody">
 <div class="add-container clearfix" id="add-block-placer">
 </div>
 <p>
  After two millennia, scientists wielding X-rays have finally revealed the text of an ancient library long thought to be unreadable.
 </p>
 <p>
  Blasted by the volcanic eruption of Mount Vesuvius that also demolished Pompeii in 79 CE, the library in Herculaneum, which contained around 1,800 rolled papyrus scrolls, has tantalized classical scholars since archaeologists first unearthed it in 1752. While many of the scrolls did not burn, they were carbonized, locking pages of ancient text into fragile tubes resembling the charcoal remnants of a campfire.
 </p>
 
            <figure class="richtext-image full-width"><img alt="SAMSUNG DIGITAL CAMERA" class="richtext-image full-width" height="448" width="800"
            src="/wgbh/nova/media/images/charred-scroll.width-800.jpg"/><figcaption>
  Scientists peered inside this fragile scroll using a special X-ray technique.
 <div class="credit"></div></figcaption>
            </figure>
            
 <p>
  Previous attempts to read the scrolls that may once have belonged to Julius Ceasar’s father-in-law have been highly damaging, chastening future would-be readers. But yesterday, an international team of scientists, led by Vito Mocella of the Institute for Microelectronics and Microsystems in Naples, Italy, and Emmanuel Brun of the European Synchotron, announced that that X-ray phase contrast tomography enabled them to read the text layered inside the scrolls without ever having to unroll them. The technique can detect differences in how similar materials—such as ancient ink and papyrus—bend light. They published their results in the journal Nature.
 </p>
 <p>
  Richard Van Noorden, reporting for Nature News, explained the technique:
 </p>
 <blockquote>
  <p>
   This is used in medicine to image the structures of soft tissues that do not absorb x-rays well, such as those in the brain, lungs and breast. It works by detecting contrast in how materials refract, rather than absorb, X-rays. Inside the Herculaneum scrolls, the inked letters are raised some 0.1 millimetres above the surface of the papyrus. That tiny bump was enough for Mocella’s team to make out the ink using coherent beams of X-rays from the European Synchrotron Radiation Facility in Grenoble, France.
  </p>
 </blockquote>
 <p>
  From those bumps, the team could read a number of Greek letters and even a few words. Mocella and Brun admit that there are several limitations to using X-ray phase contrast tomography to read ancient text, including how to decide which direction to read words that may be folded or upside down.
 </p>
 <p>
  But it does show promise, they said. “While our first experiments have revealed only small segments of writing and are in need of further refinement,” the authors wrote, once the technique has been perfected, “the imaging of an entire papyrus scroll should not require more than a few hours.”
 </p>
</section>
</div>
  

  
      <div class="rich-text"><p>
 Photo credit: D. Delattre © Bibliothèque de l'Institut de France
</p></div>
  



X-ray Vision Unveils Hidden Text in Vesuvius-Blasted Papyrus





  
      <div class="rich-text"><section class="entry-content instapaper_body clearfix" itemprop="articleBody">
 <div class="add-container clearfix" id="add-block-placer">
 </div>
 <p>
  On the outer reaches of our solar system, well past Neptune and Pluto, lurk dozens of asteroids and possible minor planets, dimly lit by the faint glow of our sun. Last week, that strange place got even stranger.
 </p>
 <p>
  On January 13, scientists from the University of Madrid and the University of Cambridge announced that the eccentricities of some of the farthest objects might be explained by the gravitational pull of two large bodies—in other words, undiscovered planets.
 </p>
 
            <figure class="richtext-image full-width"><img alt="ETNOS jpl caltech image" class="richtext-image full-width" height="449" width="800"
            src="/wgbh/nova/media/images/etnos-jpl-caltech-image-e1421874263232.width-800.jpg"/><figcaption>
  New calculations suggest that two undiscovered planets may lurk at the edge of our solar system.
 <div class="credit"></div></figcaption>
            </figure>
            
 <p>
  The team faces an uphill battle to add them to our solar system’s familiar roster. David Wilson, writing for Astrobites, urges caution:
 </p>
 <blockquote>
  <p>
   The calculations suggesting the existence of unseen planets is based on observations of only 13 KBOs [Kuiper Belt Objects], few enough that the clustering could be down to simple chance. If future observations find many more KBOs that don’t fit the pattern, then the case for missing planets will disappear. If, on the other hand, they do match what has already been seen, then their behaviour could be used to narrow down the locations of the unseen super-Earths, giving future astronomers the information they need to find them.
  </p>
 </blockquote>
 <p>
  The authors of the study—who published their results in two papers, one just this month, and an earlier one in September, in the Monthly Notices of the Royal Astronomical Society—agree that their conclusions are limited by a small sample size, but conclude their earlier paper with the argument that “the same trends are found for asteroids and comets,” and their results are unlikely to be due to Neptune’s gravitational pull or to observational bias.
 </p>
 <p>
  Fortunately, this all may be sorted out by the New Horizons spacecraft, which is scheduled to buzz Pluto this summer. The data it beams back could shed light on these mysterious gravitational forces.
 </p>
</section>
</div>
  

  
      <div class="rich-text"><p>
 Photo credit: NASA/JPL-Caltech
</p></div>
  



Our Solar System May Have Two Undiscovered Planets





  
      <div class="rich-text"><section class="entry-content instapaper_body clearfix" itemprop="articleBody">
 <div class="add-container clearfix" id="add-block-placer">
 </div>
 <p>
  Scientists have reinvented the technology that makes analyzing crime scene DNA and diagnosing infectious diseases possible—for 1/500
  <sup>
   th
  </sup>
  the cost.
 </p>
 <p>
  Today, we can distinguish human genetic material at crime scenes and detect the DNA of infectious agents in blood using a reliable, heat-dependent process called PCR. The catch is that PCR equipment usually runs into the multiple thousands of dollars—a significant barrier in resource-limited settings.
 </p>
 <p>
  So scientists at the University of California, Santa Barbara designed a system that combines the wasted heat from an over-clocked computer with the imaging capacity of a mobile phone. It works just like regular PCR, but “for a fraction of the cost,” writes Faye Walker, an author of the study. Scientists eager to convert their PCs and phones to PCR machines can find
  <a href="http://pubs.acs.org/doi/full/10.1021/ac5022419">
   the how-to guide
  </a>
  published by members of Tom Soh’s lab in September’s issue of Analytical Chemistry.
 </p>
 
            <figure class="richtext-image full-width"><img alt="heatsink" class="richtext-image full-width" height="450" width="800"
            src="/wgbh/nova/media/images/heatsink_JNKYJaj.width-800.jpg"/><figcaption>
  Computer processors can throw off a lot of heat, which is often wasted but which can be put to good use.
 <div class="credit"></div></figcaption>
            </figure>
            
 <p>
  “I think the cost effectiveness, particularly, is going to be a very attractive feature,” said Susan Montgomery, the epidemiology team lead of the Parasitic Diseases Branch at the CDC. “The equipment that’s needed for the way PCR is done in laboratories now is expensive.”
 </p>
 <p>
  PCR works by mixing a miniscule amount of DNA with chemicals and running it through cycles of heating and cooling on a machine called a thermal cycler to copy the DNA billions of times. This amplification increases the amount of DNA to levels that, when mixed with fluorescent dyes, can be seen under UV light.
 </p>
 <p>
  Kareem Ahmad, another author on the study, first considered harnessing a PC’s heat for biomedical research four and a half years into his PCR-intensive PhD. Ahmad had built a PC at home to watch movies and noticed the computer’s fan whirring loudly while he watched Netflix. When he checked the computer’s internal temperature, he saw it approaching 70˚ C. He remembers thinking, “I wonder if it could be hot enough to do PCR?”
 </p>
 <p>
  Ahmad found inexpensive software online that could cycle the internal temperature of a computer, just like a PCR machine. The next day, he decided to run a PCR experiment using the computer instead of a thermal cycler as the heat source. “The second time I did that experiment, it worked, which was unlike every other project I had worked on up until that point,” Ahmad said.
 </p>
 
            <figure class="richtext-image full-width"><img alt="heat-sink-pcr" class="richtext-image full-width" height="449" width="800"
            src="/wgbh/nova/media/images/heat-sink-pcr1.width-800.jpg"/><figcaption>
  A closeup of Kareem Ahmad's heat-sink PCR thermocycler
 <div class="credit"></div></figcaption>
            </figure>
            
 <p>
  Over the next two years, the PC-Phone-PCR (P3) system evolved until it eventually included a camera phone outfitted with a special filter and tubes pre-loaded with the necessary chemicals and fluorescent dye. Ahmad—who graduated with his PhD six months after the initial experiments—handed off the work to Faye Walker, “who did an excellent job of putting it across the finish line,” he said.
 </p>
 <p>
  Using the final P3 product, the scientists in the lab could detect parasites in human blood by adding blood to the pre-loaded tubes, boiling them briefly, placing them in the computer’s heat sink, cycling the computer’s temperature, and—under UV or blue light—using the camera to detect the presence of the now-fluorescing parasite DNA. They then used the same computer that provided the heat source to analyze the photos and determine which tubes contained blood positive for parasite infection.
 </p>
 <p>
  “I’m almost kicking myself for not coming up with it sooner, because it seems like—once you realize it—it seems like such a simple, obvious thing,” Ahmad said.
 </p>
 <p>
  “I love the idea of making things with what you have, that solve problems that you have in the field,” said Dr. Darvin Scott Smith, chief of infectious disease and geographic medicine at Kaiser Permanente. Smith would like to see this technology tested in environments where the scientists anticipate it being used and eventually see it tested on multiple diseases.
 </p>
 <p>
  Montgomery, the CDC epidemiologist, added that field-testing the P3 system, “will go a long way, I think, to pushing the argument forward that this is something that could be used in a disease control setting.”
 </p>
 <p>
  Ahmad hopes the P3 system’s practicality will make it widely adoptable. “To me, what’s cool about this technology is that it’s not actually that sophisticated, and it’s not something that is beyond the reach of most people,” he said. “It’s something that’s almost democratic.”
 </p>
</section>
</div>
  

  
      <div class="rich-text"><p>
 Photo credits:
 <a href="https://www.flickr.com/photos/jstownsley/388362245/">
  J.S. Townsley/Flickr (CC BY-NC-ND)
 </a>
 , Kareem Ahmad
</p></div>
  



Bioengineers Hack PCs and Phones to be Cheap Disease Detectors





  
      <div class="rich-text"><p>
</p>
<p>
 It was, perhaps, inevitable. Once we gained the ability to modify the DNA of an organism, it was only a matter of time before we turned that technology on ourselves and our offspring.
</p>
<p>
 Now, Chinese scientists have edited the genome of a human embryo. Their work was
 <a href="http://link.springer.com/article/10.1007/s13238-015-0153-5/fulltext.html">
  quietly published
 </a>
 late last week, on a Saturday, in the little-known, open-access journal
 <i>
  Protein &amp; Cell
 </i>
 , an unusual way to introduce a first-of-its-kind study.
</p></div>
  

  
      <div class="related"></div>
  

  
      <div class="rich-text"><p>
 Typically, such results usually appear in the pages of a handful of respected journals like
 <i>
  Science
 </i>
 or
 <i>
  Nature
 </i>
 and are surrounded by a flurry of publicity. The lead researcher, Junjui Huang of Sun Yat-sen University in Guangzhou, attempted to publish in several journals but was turned down out of ethical concerns. David Cyranoski and Sara Reardon unearthed the paper and brought it to wider attention in
 <a href="http://www.nature.com/news/chinese-scientists-genetically-modify-human-embryos-1.17378">
  an article
 </a>
 they published late yesterday in
 <i>
  Nature
 </i>
 ’s news section.
</p>
<p>
 The journals may also have balked at the mediocrity of the science itself. “It came up with relatively non-break through results,” says George Church, a professor at Harvard University. It was “a fairly technical paper that didn’t provide any brand new insights.”
</p>
<p>
 “Ethically, it is of huge significance,” says Arthur Caplan, a professor of bioethics at New York University. “The paper is much more interesting as an ethics paper than it is as a science paper. The science isn’t going to be impacted in any way by the appearance of this paper.”
</p></div>
  

  
      <div class="rich-text"><h2>
 Familiar Methods, Unfamiliar Sources
</h2>
<p>
 Much of the paper’s experimental method retraces well-trodden ground. The team used the CRISPR-Cas9 genome editing technique, a relatively new but powerful and widely-used method that allows scientists to modify genes more rapidly than before. Though the molecular machinery was first demonstrated as an editing technique in 2012, scientists have quickly become adept at wielding it, to the point where researchers at various levels—from undergraduates to tenured professors—are using it in labs around the world.
</p>
<p>
 The Chinese team’s target was the gene responsible for β-thalassaemia, an inherited blood disorder that can lead to severe anemia. In that sense, they were on the right path. “I think there’s tremendous promise in genome editing for blood disorders, and other disorders, but particularly blood disorders,” says Dr. Daniel Bauer, a professor and blood disorder researcher at the Harvard Stem Cell Institute. But, he adds, this and other disorders could be corrected by altering a person’s blood stem cells. In that case, “one wouldn’t necessarily need to modify the germ line to have a benefit in this kind of blood disorder,” he says. Dr. Suneet Agarwal, an assistant professor at the Harvard Medical School who studies gene therapy and bone marrow disorders, agrees. “I don’t think it’s safe to try and achieve a clinical cure with this type of technology. We already know that it has a long way to go in terms of its development.”
</p></div>
  

  
      <div class="ad"></div>
  

  
      <div class="rich-text"><p>
 Huang and his team said they collected embryos with the mutation from a nearby fertility clinic, according to Cyranoski and Reardon’s reporting, though little else is known about how they were created or obtained, Caplan points out. The researchers chose to modify
 <a href="http://humrep.oxfordjournals.org/content/27/suppl_1/i22.full.pdf">
  tripronuclear zygotes
 </a>
 , which are single-celled embryos that have an additional set of chromosomes. Humans, having two copies of each chromosome, are diploid. So while a triploid embryo may develop for several days or weeks, it ultimately has an extremely low chance of survival.
</p>
<p>
 Using tripronuclear zygotes allowed the researchers to study whether their edits took hold and how they affected early development. Since the embryos were unable to develop into viable fetuses, it provided the team with a modicum of ethical cover. But it also prevented them from saying anything about the viability of the modified embryos.
</p>
<p>
 Even then, the results weren’t promising. The researchers started out with 86 embryos, but just 71 made it to the end of the study. Of those, 54 were tested, and the team discovered that only 28 had successfully been modified. Worse, the CRISPR scissors missed their target often enough to be worrying. Two of the six embryos Huang’s team sequenced for off-target mutations were found to contain mistaken edits.
</p>
<h2>
 Ethical Concerns
</h2>
<p>
 Despite the fact that the embryos weren’t viable, many scientists are concerned that Huang and his group plowed ahead before the rest of the community had arrived at a consensus on how to proceed. Back in the 1970s, when researchers first discovered how to splice new bits of DNA into a genome, a technology known as recombinant DNA, they held a conference at Asilomar in California in 1975 to hash out a number of guidelines. In January of this year, scientists met in Napa, California, to do the same for genome editing. They identified a number of guidelines, including calling for a moratorium on any modifications to the earliest phases of development, known as the germline.
</p>
<p>
 “When you cross the germline bright line, you’re also opening the door to eugenic reasons—improvement, enhancement—not just disease,” Caplan says. The scientific community, he adds, hasn’t “even talked about that very much.”
</p></div>
  

  
      

<div class='pullquote'>
  <div class="rich-text"><p>
 “The paper is much more interesting as an ethics paper than it is as a science paper.”
</p></div>
</div>

  

  
      <div class="rich-text"><p>
 Modifying the germline is ethically debatable, possibly perilous, but also potentially powerful. With current gene therapies, clinicians must modify every targeted cell in the body, which could number in the trillions. But in a zygote, the stage at which the Chinese group worked, they only have to modify one. As the embryo divides, every subsequent cell should retain the modifications. But if the editing technique fails to cut in the right place, as it did in several of the Chinese group’s modified embryos, every cell will also carry unintended edits, potentially introducing new, deleterious mutations. Furthermore, in the Chinese study, not every cell in the tested embryos contained the modifications. That kind of defeats the purpose of editing the germline.
</p></div>
  

  
      <div class="newsletter"></div>
  

  
      <div class="rich-text"><p>
 Still, Church thinks this sort of experimentation should be happening, just at a more careful pace. “I’m one of the advocates of going forward cautiously,” he says. “This is one of the experiments I’m sure everybody would like to see.” Though there weren’t any breakthrough results—if the Chinese group had succeeded, Church points out, their work would certainly have been considered “more important”—he does see some value from their work. “It’s important for other safety and efficacy steps, and they even mention ways that you could improve the efficiency and specificity in the future.”
</p>
<p>
 Kevin Esvelt, a technology development fellow at Harvard’s Wyss Institute, thinks this study could help put the brakes on any fast-movers in the field. “It’s a basic first step that provides a nice cautionary tale warning against clinical attempts any time soon.”
</p>
<p>
 Despite many scientists’ reservations, this research isn’t likely to stop. Huang is hoping to refine his technique, Nature reports, either by tweaking his CRISPR-Cas9 system or using another gene editing technique like TALENs, which is more accurate and should lead to fewer off-target mutations. Furthermore, Huang’s group is not alone, Cyranoski and Reardon report. Four other groups in China are rumored to be working on editing human embryos.
</p>
<p>
 To give the scientific community and the general public more time to consider the issue, Caplan thinks we should ask researchers to stop voluntarily. “I think we should have a moratorium,” he says. “Journals should not accept papers right now.”
</p>
<p>
 “This experiment stirs attention to the fact that we need to have both national and international discussions about how to proceed, if at all,” Caplan adds. “But if we’re going to do it, we don’t do it by publishing a meaningless experiment in a third-tier journal. That’s not the way to begin.”
</p></div>
  

  
      <div class="rich-text"><p>
 Image credit: Yorgos Nikas/Wellcome Images (CC BY-NC-ND)
</p></div>
  



<p>Chinese scientists used the CRISPR-Cas9 editing technique to alter the genome of a “nonviable” human embryo.</p>

Scientists Genetically Modify Human Embryos





  
      <div class="rich-text"><p>
</p>
<p>
 Go ahead, finish off that wheel of Brie, that brick of cheddar, or that blob of mozzarella. Your heart may thank you.
</p>
<p>
 Last month, a group of Danish scientists investigated why the French don’t seem to suffer from cardiovascular disease as much as their high saturated fat, high cholesterol diets would suggest. The researchers looked to diet to explain this so-called French Paradox, and what do the French eat a lot of? Cheese. In 2013, the French led the pack in
 <a href="http://i100.independent.co.uk/article/the-10-countries-in-the-world-that-eat-the-most-cheese-revealed--gkKzi-d6vg">
  cheese consumption worldwide
 </a>
 —closely followed by Iceland and Finland.
</p>
<p>
 So the team had 15 young-to-middle aged men follow three different diets for two weeks at a time. Each diet had the same amount of calories: one was high in 1.5% milk fat, another was high in cheese, and a third allowed butter but no other dairy.
</p></div>
  

  
      <div class="related"></div>
  

  
      <div class="rich-text"><p>
 The scientists then took a close look at the men’s urine and feces to see what came out after the dairy went in. Men on the milk and cheese diets excreted higher levels of molecules called short-chain fatty acids which are thought to be anti-inflammatory and lower levels of a molecule called TMAO, made by gut microbes when they break down animal-based foods and linked to cardiovascular disease. The authors speculated that the cheese and milk might be altering gut bacteria to somehow make more of the beneficial short chain fatty acids and less of the potentially damaging TMAO.
</p>
<p>
 “The most interesting thing to me is the short chain fatty acid and immunology angle,” says Kevin Bonham, a post-doctoral scholar who studies the microbial communities in cheese and writes for the Scientific American blog,
 <a href="http://blogs.scientificamerican.com/food-matters/">
  Food Matters
 </a>
 .
 <b>
  “
 </b>
 The study size is pretty small, but at the same time it it’s certainly suggestive of an interesting link.”
</p>
<p>
 This study, despite being funded by a dairy company, aligns with other work in the field that draws correlations between cheese and dairy consumption and protective effects in cardiovascular and metabolic disease, says Gökhan Hotamisligil, chair of genetics and complex diseases at the Harvard School of Public Health.
</p></div>
  

  
      <div class="ad"></div>
  

  
      <div class="rich-text"><p>
 Not everyone is sold on cheese’s benefits, though. Kim Williams, a cardiologist at Rush University Medical Center, president of the American College of Cardiology, and a vegan, is less certain that diet explains the French Paradox. “I spent a lot of time in Paris and other parts of France, and what you don’t see is inactive people who are overweight,” he says, adding that further studies need to be done to first tease out the lifestyle factors that are contributing to it and second to compare the risk for cardiovascular disease of animal-based diets versus plant-based diets. “It shouldn’t just be more cheese versus less cheese or cheese versus butter, it actually should be a plant-based diet versus the animal products,” he says.
</p>
<p>
 “Whether or not cheese will solve French paradox, I think, remains to be seen,” Hotamisligil says. Nevertheless, “As a big cheese lover, I am loving to read these sort of findings,” he jokes. “Wine is good, cheese is good, so I’m all set.”
</p></div>
  

  
      <div class="newsletter"></div>
  

  
      <div class="rich-text"><a href="https://www.flickr.com/photos/matupplevelser/4644484638">
 Photo credit: Gunnar Magnusson (CC BY-ND 2.0)
</a></div>
  



<p>A new study suggests that eating cheese may be good for you, and it has some sound science to back it up.</p>

For a Healthy Heart, You May Have to Eat More Cheese





  
      <div class="related"></div>
  

  
      <div class="rich-text"><p>
</p>
<p>
 Scientists have just discovered a missing link between two branches on the evolutionary tree of life hiding deep under the sea, one that we’ve been looking for since 1977.
</p>
<p>
 Ever since microbiologist Carl Woese,
 <a href="http://www.pbs.org/wgbh/nova/next/evolution/carl-woese/">
  the greatest scientist you’ve never heard of
 </a>
 , added a third branch, archaea, to the existing two of prokaryotes (bacteria) and eukaryotes (which have more complex cells like our own), scientists have searched for the evolutionary connection between archaea and eukaryotes. While the reigning theory is that eukaryotes evolved from the simpler archaea, the ancestral parent of eukaryotes has remained elusive.
</p>
<p>
 But just this week, a group of scientists announced that they found that connection buried under the Arctic Ocean near a hydrothermal vent called Loki’s Castle. They named it Lokiarchaeum, and published their findings in the journal
 <a href="http://www.nature.com/nature/journal/vaop/ncurrent/full/nature14447.html">
  Nature
 </a>
 .
</p>
<p>
 Here’s Carl Zimmer, reporting for the
 <a href="http://www.nytimes.com/2015/05/07/science/under-the-sea-a-missing-link-in-the-evolution-of-complex-cells.html?rref=science&amp;module=Ribbon&amp;version=origin&amp;region=Header&amp;action=click&amp;contentCollection=Science&amp;pgtype=article">
  New York Times
 </a>
 :
</p></div>
  

  
      

<blockquote>
    <div class="rich-text"><p>
 Analyzing the DNA, the researchers found that Lokiarchaeum is far more closely related to eukaryotes than any other known species of archaea. But even more surprising was that it had genes for many traits only found before in eukaryotes.
</p>
<p>
 Among these genes were many that build special compartments inside eukaryote cells. Inside these compartments, called lysosomes, eukaryote cells can destroy defective proteins.
</p>
<p>
 All eukaryotes also share a cellular skeleton that they constantly build and tear down to change their shape. Dr. Ettema and his colleagues found many genes in Lokiarchaeum that encode the proteins required to build the skeleton.
</p></div>
</blockquote>

  

  
      <div class="rich-text"><p>
 The scientists are now trying to grow these cells in the lab to understand more about them, but it’s difficult to replicate the conditions of deep ocean hydrothermal vents. In the meantime they’re looking for more archaea that might be even closer relatives of our eukaryotic ancestors, and in turn telling us more about our own origins.
</p></div>
  

  
      <div class="ad"></div>
  

  
      <div class="newsletter"></div>
  

  
      <div class="rich-text"><p>
 Photo credit:
 <a href="https://www.flickr.com/photos/oceanexplorergov/16155517278/">
  NOAA Ocean Explorer / Flickr (CC BY-SA 2.0)
 </a>
</p></div>
  



<p>Near a hydrothermal vent, scientists discovered a missing evolutionary link that illuminates our eukaryotic past.</p>

R.A. Becker

Articles